IMMUNE THROMBOCYTOPENIC PURPURA
Clinical trials for IMMUNE THROMBOCYTOPENIC PURPURA explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIC PURPURA trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIC PURPURA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a simple antibiotic course fix a blood disorder? iraqi study investigates.
Disease control CompletedThis study tested whether treating a common stomach infection (H. pylori) could help improve low platelet counts in people with immune thrombocytopenia (ITP), a condition that increases bleeding risk. Researchers gave 100 Iraqi adults with ITP a stool test; those with the infecti…
Matched conditions: IMMUNE THROMBOCYTOPENIC PURPURA
Phase: NA • Sponsor: Al-Mustansiriyah University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New Low-Dose treatment shows promise for blood disorder
Disease control CompletedThis study tested two different low-dose treatment schedules of the drug rituximab for adults with immune thrombocytopenia (ITP), a condition where the immune system attacks blood platelets. Researchers compared giving 100 mg weekly for four weeks versus a single larger dose to s…
Matched conditions: IMMUNE THROMBOCYTOPENIC PURPURA
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Researchers dig into why cancer can trigger a dangerous blood disorder
Knowledge-focused CompletedThis study aimed to understand why some people with cancer also develop a condition called immune thrombocytopenia (ITP), which causes dangerously low platelet counts and bleeding risk. Researchers looked back at the medical records of 33 adult patients who had both ITP and cance…
Matched conditions: IMMUNE THROMBOCYTOPENIC PURPURA
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC